Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
Adicet Bio, Inc. (ACET - Free Report) is a biopharmaceutical company that discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The Zacks Consensus Estimate for its current year earnings has been revised 10% downward over the last 30 days.
Fury Gold Mines Limited (FURY - Free Report) operates as an exploration and development company. The Zacks Consensus Estimate for its current year earnings has been revised 44.4% downward over the last 30 days.
Krystal Biotech, Inc. (KRYS - Free Report) is a clinical stage biotechnology company that engages in the field of redosable gene therapy to treat serious rare diseases. The Zacks Consensus Estimate for its current year earnings has been revised 22.5% downward over the last 30 days.
Mersana Therapeutics, Inc. (MRSN - Free Report) is a clinical stage biopharmaceutical company that focuses on the development of antibody drug conjugates. The Zacks Consensus Estimate for its current year earnings has been revised 16.4% downward over the last 30 days.
NewAge, Inc. develops, markets, sells, and distributes healthy products. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:
Adicet Bio, Inc. (ACET - Free Report) is a biopharmaceutical company that discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The Zacks Consensus Estimate for its current year earnings has been revised 10% downward over the last 30 days.
Fury Gold Mines Limited (FURY - Free Report) operates as an exploration and development company. The Zacks Consensus Estimate for its current year earnings has been revised 44.4% downward over the last 30 days.
Krystal Biotech, Inc. (KRYS - Free Report) is a clinical stage biotechnology company that engages in the field of redosable gene therapy to treat serious rare diseases. The Zacks Consensus Estimate for its current year earnings has been revised 22.5% downward over the last 30 days.
Mersana Therapeutics, Inc. (MRSN - Free Report) is a clinical stage biopharmaceutical company that focuses on the development of antibody drug conjugates. The Zacks Consensus Estimate for its current year earnings has been revised 16.4% downward over the last 30 days.
NewAge, Inc. develops, markets, sells, and distributes healthy products. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on ACET - FREE
Get the latest research report on KRYS - FREE
Get the latest research report on MRSN - FREE
Get the latest research report on FURY - FREE